Dominik Wolf
Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
Bösch M, Horvath L, Baty F, Pircher A, Wolf D, Spahn S, Straussman R, Tilg H, Brutsche M. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects. J Immunother Cancer 2022; 10
Nov 1, 2022Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
Nov 1, 2022J Immunother Cancer 2022; 10
Bösch Maximilian, Horvath Lena, Baty Florent, Pircher Andreas, Wolf Dominik, Spahn Stephan, Straussman Ravid, Tilg Herbert, Brutsche Martin H
Call for a holistic framework for cancer immunotherapy.
Boesch M, Baty F, Kowatsch T, Wolf D, Früh M, Brutsche M. Call for a holistic framework for cancer immunotherapy. Cancer 2022; 128:3772-3774.
Sep 15, 2022Call for a holistic framework for cancer immunotherapy.
Sep 15, 2022Cancer 2022; 128:3772-3774
Boesch Maximilian, Baty Florent, Kowatsch Tobias, Wolf Dominik, Früh Martin, Brutsche Martin H
High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome
Wolf D, Reimer D, Hartmann G, Sopper S, Sprung S, Marth C, Wieser V, Zeimet A, Fiegl H, Bösch M. High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome. Int J Cancer 2019
Dec 4, 2019High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome
Dec 4, 2019Int J Cancer 2019
Wolf Dominik, Reimer Daniel, Hartmann Gunther, Sopper Sieghart, Sprung Susanne, Marth Christian, Wieser Verena, Zeimet Alain G, Fiegl Heidi, Bösch Maximilian
Fibroblasts in cancer: Defining target structures for therapeutic intervention
Bösch M, Baty F, Rumpold H, Sopper S, Wolf D, Brutsche M. Fibroblasts in cancer: Defining target structures for therapeutic intervention. Biochim Biophys Acta Rev Cancer 2019; 1872:111-121.
Jun 29, 2019Fibroblasts in cancer: Defining target structures for therapeutic intervention
Jun 29, 2019Biochim Biophys Acta Rev Cancer 2019; 1872:111-121
Bösch Maximilian, Baty Florent, Rumpold Holger, Sopper Sieghart, Wolf Dominik, Brutsche Martin
Ovarian Cancer Stem Cell Heterogeneity
Hatina J, Bösch M, Sopper S, Kripnerova M, Wolf D, Reimer D, Marth C, Zeimet A. Ovarian Cancer Stem Cell Heterogeneity. Adv Exp Med Biol 2019; 1139:201-221.
Jan 1, 2019Ovarian Cancer Stem Cell Heterogeneity
Jan 1, 2019Adv Exp Med Biol 2019; 1139:201-221
Hatina Jiri, Bösch Maximilian, Sopper Sieghart, Kripnerova Michaela, Wolf Dominik, Reimer Daniel, Marth Christian, Zeimet Alain G
Evaluation of Vav3.1 as prognostic marker in endometrial cancer
Bösch M, Reimer D, Wolf D, Hatina J, Rössler J, Wiedemair A, Fiegl H, Marth C, Sopper S, Zeimet A. Evaluation of Vav3.1 as prognostic marker in endometrial cancer. J Cancer Res Clin Oncol 2018; 144:2067-2076.
Aug 6, 2018Evaluation of Vav3.1 as prognostic marker in endometrial cancer
Aug 6, 2018J Cancer Res Clin Oncol 2018; 144:2067-2076
Bösch Maximilian, Reimer Daniel, Wolf Dominik, Hatina Jiri, Rössler Julia, Wiedemair Annemarie, Fiegl Heidi, Marth Christian, Sopper Sieghart, Zeimet Alain G
(Iso-)form Matters: Differential Implication of Vav3 Variants in Ovarian Cancer
Bösch M, Reimer D, Sopper S, Wolf D, Zeimet A. (Iso-)form Matters: Differential Implication of Vav3 Variants in Ovarian Cancer. Oncologist 2018; 23:757-759.
Apr 19, 2018(Iso-)form Matters: Differential Implication of Vav3 Variants in Ovarian Cancer
Apr 19, 2018Oncologist 2018; 23:757-759
Bösch Maximilian, Reimer Daniel, Sopper Sieghart, Wolf Dominik, Zeimet Alain G
Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response
Reimer D, Hackl H, Parson W, Altevogt P, Hatina J, Sopper S, Marth C, Wolf D, Bösch M, Zeimet A. Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response. Int J Cancer 2017; 142:1640-1651.
Dec 14, 2017Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response
Dec 14, 2017Int J Cancer 2017; 142:1640-1651
Reimer Daniel, Hackl Hubert, Parson Walther, Altevogt Peter, Hatina Jiri, Sopper Sieghart, Marth Christian, Wolf Dominik, Bösch Maximilian, Zeimet Alain G
Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples
Bösch M, Hoflehner E, Wolf D, Gastl G, Sopper S. Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples. J Vis Exp 2017
May 10, 2017Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples
May 10, 2017J Vis Exp 2017
Bösch Maximilian, Hoflehner Elisabeth, Wolf Dominik, Gastl Guenther, Sopper Sieghart
Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche
Bösch M, Sopper S, Zeimet A, Reimer D, Gastl G, Ludewig B, Wolf D. Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche. Biochim Biophys Acta 2016; 1866:276-289.
Oct 15, 2016Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche
Oct 15, 2016Biochim Biophys Acta 2016; 1866:276-289
Bösch Maximilian, Sopper Sieghart, Zeimet Alain G, Reimer Daniel, Gastl Guenther, Ludewig Burkhard, Wolf Dominik
Ionophore Antibiotics as Cancer Stem Cell-Selective Drugs: Open Questions
Bösch M, Sopper S, Wolf D. Ionophore Antibiotics as Cancer Stem Cell-Selective Drugs: Open Questions. Oncologist 2016; 21:1291-1293.
Aug 2, 2016Ionophore Antibiotics as Cancer Stem Cell-Selective Drugs: Open Questions
Aug 2, 2016Oncologist 2016; 21:1291-1293
Bösch Maximilian, Sopper Sieghart, Wolf Dominik
High prevalence of side population in human cancer cell lines
Bösch M, Zeimet A, Fiegl H, Wolf B, Huber J, Klocker H, Gastl G, Sopper S, Wolf D. High prevalence of side population in human cancer cell lines. Oncoscience 2016; 3:85-87.
Apr 10, 2016High prevalence of side population in human cancer cell lines
Apr 10, 2016Oncoscience 2016; 3:85-87
Bösch Maximilian, Zeimet Alain G, Fiegl Heidi, Wolf Barbara, Huber Julia, Klocker Helmut, Gastl Guenther, Sopper Sieghart, Wolf Dominik
Optimized Stem Cell Detection Using the DyeCycle-Triggered Side Population Phenotype
Bösch M, Wolf D, Sopper S. Optimized Stem Cell Detection Using the DyeCycle-Triggered Side Population Phenotype. Stem Cells Int 2015; 2016:1652389.
Dec 20, 2015Optimized Stem Cell Detection Using the DyeCycle-Triggered Side Population Phenotype
Dec 20, 2015Stem Cells Int 2015; 2016:1652389
Bösch Maximilian, Wolf Dominik, Sopper Sieghart
Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics
Bösch M, Zeimet A, Rumpold H, Gastl G, Sopper S, Wolf D. Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics. Stem Cells Transl Med 2015; 4:1028-32.
Jul 1, 2015Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics
Jul 1, 2015Stem Cells Transl Med 2015; 4:1028-32
Bösch Maximilian, Zeimet Alain G, Rumpold Holger, Gastl Guenther, Sopper Sieghart, Wolf Dominik
The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics
Bösch M, Wolf D, Hatina J, Spoeck F, Parson W, Gastl G, Schmidt S, Reimer D, Zeimet A, Sopper S. The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics. Oncotarget 2014; 5:7027-39.
Aug 30, 2014The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics
Aug 30, 2014Oncotarget 2014; 5:7027-39
Bösch Maximilian, Wolf Dominik, Hatina Jiri, Spoeck Franziska, Parson Walther, Gastl Guenther, Schmidt Stefan, Reimer Daniel, Zeimet Alain G, Sopper Sieghart
DyeCycle Violet used for side population detection is a substrate of P-glycoprotein
Bösch M, Reimer D, Rumpold H, Zeimet A, Sopper S, Wolf D. DyeCycle Violet used for side population detection is a substrate of P-glycoprotein. Cytometry A 2012; 81:517-22.
Mar 7, 2012DyeCycle Violet used for side population detection is a substrate of P-glycoprotein
Mar 7, 2012Cytometry A 2012; 81:517-22
Bösch Maximilian, Reimer Daniel, Rumpold Holger, Zeimet Alain G, Sopper Sieghart, Wolf Dominik